| The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial D Grimwade, H Walker, F Oliver, K Wheatley, C Harrison, G Harrison, ... Blood, The Journal of the American Society of Hematology 92 (7), 2322-2333, 1998 | 3361 | 1998 |
| Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger … D Grimwade, RK Hills, AV Moorman, H Walker, S Chatters, AH Goldstone, ... Blood, The Journal of the American Society of Hematology 116 (3), 354-365, 2010 | 2170 | 2010 |
| The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to … PD Kottaridis, RE Gale, ME Frew, G Harrison, SE Langabeer, AA Belton, ... Blood, The Journal of the American Society of Hematology 98 (6), 1752-1759, 2001 | 1945 | 2001 |
| Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial DC Linch, AH Goldstone, A McMillan, R Chopra, GV Hudson, D Winfield, ... The Lancet 341 (8852), 1051-1054, 1993 | 1331 | 1993 |
| Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease … N Schmitz, B Pfistner, M Sextro, M Sieber, AM Carella, M Haenel, ... The Lancet 359 (9323), 2065-2071, 2002 | 1312 | 2002 |
| The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom … D Grimwade, H Walker, G Harrison, F Oliver, S Chatters, CJ Harrison, ... Blood, The Journal of the American Society of Hematology 98 (5), 1312-1320, 2001 | 1183 | 2001 |
| Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study AK Fielding, SM Richards, R Chopra, HM Lazarus, MR Litzow, G Buck, ... Blood 109 (3), 944-950, 2007 | 908 | 2007 |
| In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and … AH Goldstone, SM Richards, HM Lazarus, MS Tallman, G Buck, ... Blood, The Journal of the American Society of Hematology 111 (4), 1827-1833, 2008 | 895 | 2008 |
| Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council … AV Moorman, CJ Harrison, GAN Buck, SM Richards, LM Secker-Walker, ... Blood 109 (8), 3189-3197, 2007 | 833 | 2007 |
| Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients N Schmitz, P Dreger, DC Linch, AH Goldstone, MA Boogaerts, ... The Lancet 347 (8998), 353-357, 1996 | 793 | 1996 |
| Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993 JM Rowe, G Buck, AK Burnett, R Chopra, PH Wiernik, SM Richards, ... Blood 106 (12), 3760-3767, 2005 | 790 | 2005 |
| A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not … AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, RK Hills, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 749 | 2007 |
| Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial AK Burnett, RK Hills, D Milligan, L Kjeldsen, J Kell, NH Russell, JAL Yin, ... Journal of clinical oncology 29 (4), 369-377, 2011 | 739 | 2011 |
| Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial AK Burnett, AH Goldstone, RMF Stevens, IM Hann, JKH Rees, RG Gray, ... The Lancet 351 (9104), 700-708, 1998 | 709 | 1998 |
| In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ... Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000 | 603 | 2000 |
| Hepatitis B transmission from contaminated cryopreservation tank RS Tedder, MA Zuckerman, NS Brink, AH Goldstone, A Fielding, S Blair, ... The Lancet 346 (8968), 137-140, 1995 | 577 | 1995 |
| A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial K Wheatley, AK Burnett, AH Goldstone, RG Gray, IM Hann, CJ Harrison, ... British journal of haematology 107 (1), 69-79, 1999 | 531 | 1999 |
| Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial AH Goldstone, AK Burnett, K Wheatley, AG Smith, RM Hutchinson, ... Blood, The Journal of the American Society of Hematology 98 (5), 1302-1311, 2001 | 529 | 2001 |
| Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid … AK Burnett, D Grimwade, E Solomon, K Wheatley, AH Goldstone Blood, The Journal of the American Society of Hematology 93 (12), 4131-4143, 1999 | 482 | 1999 |
| Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers RS Maser, B Choudhury, PJ Campbell, B Feng, KK Wong, A Protopopov, ... Nature 447 (7147), 966-971, 2007 | 449 | 2007 |
